← Issue №20/ week of Nov 15, 2026/Nutrition

Feasibility and safety of an automated chyme reinfusion device for high-output stomas and enterocutaneous fistulas in hospitalized adults: A descriptive cohort study.

From GI Signals issue №20: what this paper found, what it changes, and where it sits against the current standard of care, reviewed by Simon Mathews, MD.

Nutrition prospective cohort · n=12 · Nov 15, 2026 · JPEN · IF 3.2

Feasibility and safety of an automated chyme reinfusion device for high-output stomas and enterocutaneous fistulas in hospitalized adults: A descriptive cohort study.

New evidenceenteral nutritionparenteral nutritionshort bowel syndromeartificial intelligence
Clinical takeawayNo clinical action yet: this is a small descriptive cohort study; prospective trials are needed to confirm safety and efficacy.
ContextThis literature reports that chyme reinfusion using an automated device is technically feasible and safe for hospitalized adults with high-output stomas or enterocutaneous fistulas.
No standard claimed for this paper

Every paper is compared to the standard governing its question. This one is not: either no standard in the corpus matches it, or the comparison did not hold up on review and was withdrawn rather than published unverified. Both are logged.

Boros M … Ris F · JPEN. Journal of Parenteral and Enteral Nutrition · IF 3.2 · PubMed ↗Permalink
← Read the whole of issue №20 Every paper GI Signals surfaces gets a page like this one. All issues